Prime ASI S.A. conducts activities related to the development and commercialization of injection into the eye in Europe and the world. Prime ASI is developing the eye injection device. Until 2017 the company wants to apply for the registration of an ophthalmic device in the US and the European Union. It will have the advantage of Dynamic Pressure Sensing technology, which is obtained from Milestone Scientific, AOS parent company listed in the US.
Headquarters
ul. Stanislawa Moniuszki 8
Rzeszow; Podkarpackie;
Postal Code: 35-015
Contact Details: Purchase the Prime ASI S.A. report to view the information.
Website: http://www.primeasi.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service